Wavefer S 100mg Injection contains Iron Sucrose (20mg/5ml) as its active ingredient and is indicated for the treatment of iron deficiency anemia, particularly in patients with chronic kidney disease undergoing hemodialysis or those who are intolerant or unresponsive to oral iron therapy. This parenteral iron preparation facilitates rapid replenishment of iron stores by providing bioavailable iron directly into the bloodstream, thereby enhancing erythropoiesis and improving hemoglobin levels. The injection is administered intravenously under medical supervision, ensuring controlled and gradual iron delivery to minimize the risk of adverse reactions. Wavefer S is especially beneficial in cases where oral iron absorption is impaired or when immediate correction of iron deficiency is clinically warranted. It is contraindicated in patients with known hypersensitivity to iron sucrose or any component of the formulation, and caution is advised in individuals with active infections or iron overload disorders. Common adverse effects may include transient hypotension, nausea, or injection site reactions, which are generally mild and self-limiting. Regular monitoring of serum ferritin, transferrin saturation, and hemoglobin levels is recommended to guide therapy and prevent iron overload. Wavefer S 100mg Injection offers a safe and effective option for the management of iron deficiency anemia in appropriate clinical settings.